Alvotech (ALVO)
12.44
+0.02
(+0.16%)
USD |
NASDAQ |
Nov 21, 16:00
12.40
-0.04
(-0.32%)
After-Hours: 20:00
Alvotech Revenue (Quarterly): 102.89M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 102.89M |
| June 30, 2024 | 198.74M |
| March 31, 2024 | 36.85M |
| December 31, 2023 | 53.39M |
| September 30, 2023 | 17.79M |
| June 30, 2023 | 4.391M |
| Date | Value |
|---|---|
| March 31, 2023 | 15.86M |
| December 31, 2022 | 23.86M |
| September 30, 2022 | 19.05M |
| June 30, 2022 | 39.67M |
| March 31, 2022 | 0.452M |
| December 31, 2021 | 34.76M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.452M
Minimum
Mar 2022
198.74M
Maximum
Jun 2024
45.64M
Average
29.31M
Median
Revenue (Quarterly) Benchmarks
| Procaps Group SA | 118.41M |
| Johnson & Johnson | 22.47B |
| Pfizer Inc | 17.70B |
| Rigel Pharmaceuticals Inc | 55.31M |
| NovaBay Pharmaceuticals Inc | 2.441M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.39M |
| Total Expenses (Quarterly) | 90.16M |
| EPS Diluted (Quarterly) | -0.02 |
| Enterprise Value | 4.654B |
| Gross Profit Margin (Quarterly) | 61.31% |
| Profit Margin (Quarterly) | -11.07% |
| Earnings Yield | -14.92% |
| Normalized Earnings Yield | -8.846 |